Protective effect of tetramethylpyrazine on myocardial ischemia-reperfusion injury

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Qian, Weidong ^a   Xiong, Xingjiang ^b   Fang, Zhuyuan ^c   Lu, Haiting ^a   Wang, Zhensheng ^a  

^a AFFILIATED HOSPITAL OF NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^c THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CARDIAC AGENT; OXYGEN RADICAL; TETRAMETHYLPYRAZINE;

APOPTOSIS; CALCIUM HOMEOSTASIS; CALCIUM OVERLOAD; CARDIOVASCULAR EFFECT; CELL DAMAGE; CELL FUNCTION; ENDOTHELIUM CELL; ENERGY METABOLISM; HEART MITOCHONDRION; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; INFLAMMATION; INTOXICATION; LIPID PEROXIDATION; MYOCARDIAL ISCHEMIA REPERFUSION INJURY; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW;

EID: 84933188835     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/107501     Document Type: Review

References (73)

1. L. C. Becker and G. Ambrosio, "Myocardial consequences of reperfusion," Progress in Cardiovascular Diseases, vol. 30, no. 1, pp. 23-44, 1987.
2. A. T. Turer and J. A. Hill, "Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy," The American Journal of Cardiology, vol. 106, no. 3, pp. 360-368, 2010.
3. D. S. Villanueva, P. Poirier, P. R. Standley, and T. L. Broderick, "Prevention of ischemic heart failure by exercise in spontaneously diabetic BB Wor rats subjected to insulin withdrawal," Metabolism, vol. 52, no. 6, pp. 791-797, 2003.
4. G. Lopaschuk, "Regulation of carbohydrate metabolism in ischemia and reperfusion," American Heart Journal, vol. 139, no. 2, pp. S115-S119, 2000.
5. M. A. Nordlie, L. E. Wold, B. Z. Simkhovich, C. Sesti, and R. A. Kloner, "Molecular aspects of ischemic heart disease: ischemia/reperfusion-induced genetic changes and potential applications of gene and RNA interference therapy," Journal of Cardiovascular Pharmacology and Terapeutics, vol. 11, no. 1, pp. 17-30, 2006.
6. W. T. Wang, Z. J. Xu, L. N. Lin et al., "Efect of ligustrazine on myocardial cell energy metabolism in the reperfusion injury afer myocardial ischemia in rabbits," Chinese Journal of Critical Care Medicine, vol. 23, no. 3, pp. 129-130, 2003.
7. H. B. Zhu, M. M. Wang, and B. Zhang, "Efect of myocar-dial ischemia reperfusion in rabbits on Na+-K+-ATPase and protective efect of ligustrazine pretreatment," Hubei Journal of Traditional Chinese Medicine, vol. 32, no. 8, pp. 5-6, 2010.
8. D. Z. Shi, K. J. Chen, and P. Zhong, "The efects of ligustrazine on synthesis of protein and RNA, and NOS gene expression in cultural myocardial cells with hypoxia and lack of sugar," Chinese Pharmaceutical Journal, vol. 33, no. 12, pp. 724-726, 1998.
9. Z. M. Wang, Z. J. Xu, and W. T. Wang, "Ultrastructural changes of myocardial ischemia reperfusion injury in rabbits and protective efects of ligustrazine," Journal of Wenzhou Medical College, vol. 28, no. 1, pp. 15-17, 1998.
10. F. S. Wan, B. Liu, X. M. Zhao et al., "Efects of ligustrazine on respiratory enzymes inthe myocardial mitochondria of the ischemia-reperfusion rats," Chinese Journal of Pathophysiology, vol. 17, no. 1, p. 58, 2001.
11. Y. Li, F. S. Wan, Y. F. Wan et al., "Protective efects of ligustrazine against myocardial ischemia injury of rat," Chinese Traditional Patent Medicine, vol. 25, no. 8, pp. 646-648, 2003.
12. W. T. Wang, F. Y. Wang, W. Wang et al., "Efect of ligustrazine and L-arginine on function of mitochondria in myocardial cell in the reperfusion injury afer myocardial ischemia in rabbits," Chinese Journal of Arteriosclerosis, vol. 14, no. 11, p. 955, 2006.
13. N. Galang, H. Sasaki, and N. Maulik, "Apoptotic cell death during ischemia/reperfusion and its attenuation by antioxidant therapy," Toxicology, vol. 148, no. 2-3, pp. 111-118, 2000.
14. A. A. Wolf, H. H. Rotmensch, W. C. Stanley, and R. Ferrari, "Metabolic approaches to the treatment of ischemic heart disease: the clinicians' perspective," Heart Failure Reviews, vol. 7, no. 2, pp. 187-203, 2002.
15. J. Du, C. J. Wang, and Z. M. Jing, "Study on damage of calcium overload and the role of oxygen free radical mechanism of myocardial ischemia reperfusion," Health Vocational Education, vol. 27, no. 11, pp. 121-123, 2009.
16. Z. Zhang, T. Wei, J. Hou, G. Li, S. Yu, and W. Xin, "Tetram-ethylpyrazine scavenges superoxide anion and decreases nitric oxide production in human polymorphonuclear leukocytes," Life Sciences, vol. 72, no. 22, pp. 2465-2472, 2003.
17. Z. H. Zhang, S. Z. Yu, Z. T. Wang et al., "Scavenging efects of tetramethylpyrazine on active oxygen free radicals," Acta Pharmacologica Sinica, vol. 15, no. 3, pp. 229-231, 1994.
18. C. F. Liu, C. H. Lin, C. F. Chen, T. Huang, and S. Lin, "Antioxidative efects of tetramethylpyrazine on acute ethanol-induced lipid peroxidation," The American Journal of Chinese Medicine, vol. 33, no. 6, pp. 981-988, 2005.
19. F. Wang, L. Z. Shang, J. R. Wang et al., "Efect and mechanism of chuanxiongzine pretreatment on rats myocardial ischemia reperfusion injury," Henan Journal of Traditional Chinese Medicine, vol. 28, no. 4, pp. 26-28, 2008.
20. S.Y. Chen, G. Hsiao, H. R. Hwang, P. Cheng, and Y. Lee, "Tetramethylpyrazine induces heme oxygenase-1 expression and attenuates myocardial ischemia/reperfusion injury in rats," Journal of Biomedical Science, vol. 13, no. 5, pp. 731-740, 2006.
21. Z. J. Xu, W. T. Wang, and D. Li, "Protective efects of ligustrazine on myocardial ischemia reperfusion injury in rabbits and its mechanism," Basic Medical Science and Clinics, vol. 17, no. 4, pp. 68-71, 1997.
22. F. S. Wan, X. M. Zhao, B. Liu et al., "Protective efects of ligustrazine on myocardial ischemia reperfusion injury in rats," Journal of Clinical Pharmacology and Terapeutics, vol. 3, no. 3, pp. 184-186, 1998.
23. Q. F. Zhang, L. J. Chen, and M. Li, "Protective efects of ligustrazine on myocardial ischemia reperfusion injury in rats," China Medical Herald, vol. 6, no. 9, pp. 17-18, 2009.
24. Y. C. Gu, X. L. Yu, and W. J. Guo, "Protective efect of tetramethylpyrazine postconditioning on ischemia reperfusion injured myocardium in rats," International Journal of Cardiovascular Disease, vol. 36, no. 5, pp. 304-307, 2009.
25. F. S. Wan, B. Liu, X. M. Zhao et al., "Efects of ligustrazine on respiratory enzymes in the myocardial mitochondria of the ischemia reperfusion rats," Chinese Journal of Pathophysiology, vol. 17, no. 1, pp. 58-60, 2001.
26. Z. G. Piao, H. S. Piao, G. C. Jin et al., "An experimental study of ligustrazine on ischemic myocardial protection and scavenging oxygen free radical," Chinese Wild Plant Resources, vol. 19, no. 5, pp. 46-48, 2000.
27. X. X. Zhang, J. P. Zhang, and L. J. Chen, "To study the protective efect of ligustrazine on myocardial cell injury," Chinese Community Doctors, vol. 11, no. 18, article 3, 2009.
28. Y. P. Zhou and Q. Liu, "Protective efects of ligustrazine on hypoxia/reoxygenation injury in cardiomyocytes," Practical Clinical Medicine, vol. 12, no. 2, pp. 5-7, 2011.
29. D. Chen, D. Liu, G. H. Zeng et al., "HSP70 mediated delayed protective efect of ligustrazine preconditioning on isolated rat heart," Pharmacology and Clinics of Chinese Material Medica, vol. 23, no. 5, pp. 80-83, 2007.
30. X. C. Qin, G. Q. Fen, R. F. Fu et al., "Experimental study on the protective efect of ligustrazine on myocardialischemia reperfusion injury in rats," Henan Journal of Traditional Chinese Medicine, vol. 17, no. 5, pp. 274-276, 1997.
31. Y. L. Yue, H. M. Li, Z. F. Zhao et al., "Protective efects of ligustrazine on hemorrhagic shock and reperfusion injury in rabbits," Journal of Xi'An Medical University, vol. 19, no. 1, pp. 4-7, 1998.
32. M. Ruiz-Meana and D. García-Dorado, "Pathophysiology of ischemia reperfusion injury: new therapeutic options for acute myocardial infarction," Revista Espanola de Cardiologia, vol. 62, no. 2, pp. 199-209, 2009.
33. M. R. Siegfried, J. Erhardt, T. Rider, X.-. Ma, and A. M. Lefer, "Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion," The Journal of Pharmacology and Experimental Terapeutics, vol. 260, no. 2, pp. 668-675, 1992.
34. G. S. Zhao, H. J. Yang, Z. Y. Zhou et al., "To study the efect of ligustrazine reperfusion efect," Chinese Emergency Medicine, vol. 6, no. 5, pp. 222-224, 1997.
35. G. S. Zhao, H. J. Yang, B. H. Zuo et al., "Comparison of protective efects of ligustrazine and danshen on oxygen paradox in isolated rat hearts," Tianjin Medical Journal, vol. 24, no. 5, pp. 289-292, 1996.
36. F. Run-Fang, F. Guo-Qing, L. Jie, F. Guo-Yi, and W. Shi-Ai, "Protective efect of prostaglandin E1 combined with ligustrazine on myocardial ischemia reperfusion injury in rats," Chinese Pharmacological Bulletin, vol. 14, no. 6, pp. 548-550, 1998.
37. P. K. T. Pang, J. J. Shan, and K. W. Chiu, "Tetramethylpyrazine, a calcium antagonist," Planta Medica, vol. 62, no. 5, pp. 431-435, 1996.
38. H. Xu, "Ligustrazine cardiovascular pharmacology and calcium antagonism," Chinese Journal of Integrated Traditional and Western Medicine, vol. 23, no. 5, pp. 376-377, 2003.
39. Y. Li, T. C. Wang, W. Q. Gong et al., "Efects of ligustrazine on Fas protein expression of myocardial ischemia reperfusion in rats," Journal of Fourth Military Medical University, vol. 20, no. 6, pp. 515-518, 1999.
40. L. M. Xia and J. X. Wu, "Efects of ligustrazine on dysfunction of myocardial nuclear calcium transport," Chinese Journal of Clinical Pharmacology and Terapeutics, vol. 7, no. 2, pp. 124-126, 2002.
41. X. Zhang, W. Liu, J. Zhou, and C. Fan, "Studies on protection and mechanism of tetramethylpyrazine on myocardial injury of rats with DHF," China Journal of Chinese Materia Medica, vol. 34, no. 21, pp. 2808-2812, 2009.
42. C. Zhou, Y. Liu, L. Guan, and H. Wang, "Inhibitory efects of tetramethylpyrazine on early aferdepolarizations induced by calcium paradox injury in myocardium of rats ex vivo," Chinese Journal of Clinical Rehabilitation, vol. 10, no. 39, pp. 104-106, 2006.
43. K. Shiroto, H. Otani, F. Yamamoto, C. Huang, N. Maulik, and D. K. Das, "MK2-/- gene knockout mouse hearts carry anti-apoptotic signal and are resistant to ischemia reperfusion injury," Journal of Molecular and Cellular Cardiology, vol. 38, no. 1, pp. 93-97, 2005.
44. K. Y. Kwon, C. H. Cho, S. P. Kim, C. K. Park, and S. H. Jheon, "Apoptosis induced by preservation and reperfusion in canine lung transplantation," Transplantation Proceedings, vol. 35, no. 1, pp. 134-137, 2003.
45. H. Duan, Y. Li, S. H. Zhang et al., "Efects of ligustrazine on apoptosis in rats with myocardial ischemia reper fusion injury," Chinese Journal of Cardiology, vol. 27, no. 4, pp. 294-296, 1999.
46. D. J. Xie, R. H. Chen, H. L. Ren et al., "Interference of myocardial apoptosis in pressure overload SD rats with tetram-ethylpyrazine," Chinese Heart Journal, vol. 16, no. 1, pp. 26-28, 2004.
47. J. Wan, D. Ye, P. Wu, L. Zhang, X. Gong, and Y. Huang, "Efect of tetramethylpyrazine on lipopolysaccharides induced macrophage cyclo-oxidase-2 expression and apoptosis of cardiac myocytes," Chinese Journal of Integrated Traditional and Western Medicine, vol. 24, no. 10, pp. 906-911, 2004.
48. J. Liu and P. W. Niu, "Protective efects of chuan xiong qin against ischemia-reperfusion injury in rats," China Practical Medicine, vol. 6, no. 2, pp. 29-30, 2011.
49. X. Cheng, L. Zhang, J. Hu, L. Sun, and G. Du, "Neuroprotective efects of tetramethylpyrazine on hydrogen peroxide-induced apoptosis in PC12 cells," Cell Biology International, vol. 31, no. 5, pp. 438-443, 2007.
50. G. M. Zhang, W. F. Wang, X. P. Wang et al., "The myocardial apoptosis and the expression of Fas and FasL genes in ischemic myocardium of rats," Progress of Anatomical Sciences, vol. 15, no. I, pp. 100-102, 2009.
51. J. Zhang, L. Q. Liu, L. H. Yu et al., "Efects of ligustrazine on the apoptosis in rats with myocardial ischemia reperfusion injury," Acta Academiae Medicine Jiangxi, vol. 47, no. 6, pp. 20-22, 2007.
52. Z. Y. Zhai, J. H. Yang, S. T. Zhang et al., "Role of Janus kinase 2/signal transducer and activator of transcription 3 signaling pathway in attenuation of myocardial ischemia-reperfusion injury by teramethylpyrazine in rats," Chinese Journal of Anes-thesiology, vol. 31, no. 8, pp. 1005-1008, 2011.
53. R. Y. Zhao, W. Hao, X. J. Meng et al., "Efects of ligustrazine ferulate postconditioning on myocardial ischemia reperfusion injury in rats," Journal of China Medical University, vol. 41, no. II, pp. 1018-1021, 2012.
54. N. G. Frangogiannis, C. W. Smith, and M. L. Entman, "The infammatory response in myocardial infarction," Cardiovascular Research, vol. 53, no. 1, pp. 31-47, 2002.
55. S.-L. Liao, T.-K. Kao, W.-Y. Chen et al., "Tetramethylpyrazine reduces ischemic brain injury in rats," Neuroscience Letters, vol. 372, no. 1-2, pp. 40-45, 2004.
56. L. Zhang, "Research progress on mechanism of of prevention and treatment of Chinese medicinal herb on myocardial ischemia reperfusion injury," Liaoning Journal of Traditional Chinese Medicine, vol. 37, no. 10, pp. 2070-2072, 2010.
57. M. F. Hu, L. Z. Shang, and D. W. Wei, "Protective efects of ligustrazine on myocardial ischemia reperfusion injury in rats," Shanghai Journal of Traditional Chinese Medicine, vol. 42, no. 4, pp. 66-68, 2008.
58. M. P. Castaneda, A. Swiatecka-Urban, M. M. Mitsnefes et al., "Activation of mitochondrial apoptotic pathways in human renal allografs afer ischemia-reperfusion injury," Transplantation, vol. 76, no. 1, pp. 50-54, 2003.
59. L. Z. Shang, F. Wang, and J. R. Wang, "The efects of ligustrazine on expression of p38MAPK and TNF-c in rats with myocardial ischemia reperfusion injury," Journal of Henan University of Chinese Medicine, vol. 23, no. 5, pp. 24-25, 2008.
60. Z. H. Pan and X. Jin, "Protective efects of combination of ligustrazine and ferulic acid on myocardial injury induced by ischemia and reperfusion in rats," Tianjin Medical Journal, vol. 36, no. 10, pp. 796-798, 2008.
61. J. R. Yang, M. X. Zhang, L. T. Chang et al., "Protective efects of ligustrazine, ferulic acid and their combination on myocardial injury induced by ischemia-reperfusion in rats," Chinese Traditional and Herbal Drugs, vol. 39, no. 7, pp. 1054-1056, 2008.
62. Y. Wang, S. H. Mi, S. J. Jia et al., "Research progress in drug treatment of myocardial ischemia reperfusion injury," Chinese Journal of Practical Internal Medicine, vol. 32, no. 12, pp. 958-960, 2012.
63. D. Fulton, J. P. Gratton, T. J. Mccabe et al., "Regulation of endothelium-derived nitric oxide production by the protein kinase Akt," Nature, vol. 399, no. 6736, pp. 597-601, 1999.
64. L. Lv, S. Jiang, J. Xu, J. Gong, and Y. Cheng, "Protective efect of ligustrazine against myocardial ischaemia reperfusion in rats: the role of endothelial nitric oxide synthase," Clinical and Experimental Pharmacology and Physiology, vol. 39, no. 1, pp. 20-27, 2012.
65. R. X. Liang, F. L. Liao, and D. Han, "Study of mechanism by ligustrazine preconditioning protection on myocardial ischemia and reperfussion injury," Pharmacology and Clinics of Chinese Material Medica, vol. 17, no. 3, pp. 8-10, 2001.
66. H. P. Chen, M. He, Q. R. Huang, G. Zeng, and D. Liu, "Delayed protection of tetramethylpyrazine on neonatal rat cardiomy-ocytes subjected to anoxia-reoxygenation injury," Basic and Clinical Pharmacology and Toxicology, vol. 100, no. 6, pp. 366-371, 2007.
67. C. Q. Li and Y. X. Li, "Protective efects be related with adipeincton ligustrzaine on myocardial ischemia reperfusion injury," Guide of China Medicine, vol. 8, no. 36, pp. 215-216, 2010.
68. W. T. Wang, Z. J. Xu, and L. N. Lin, "Efect of ligustrazine on nitric oxide and endothelin in the reperfusion injury afer myocardial ischemia in rabbits," Chinese Journal of Pathopsiol-ogy, vol. 17, no. 3, pp. 230-234, 2001.
69. R. X. Liang, T. Z. Guan, F. L. Liao et al., "Ligustrazine preconditioning protects endothelium from myocardial ischemia and reperfussion injury in rats," Chinese Journal of Microcirculation, vol. 12, no. 4, pp. 4-5, 2002.
70. M. Li, M. Q. Zhao, S. S. K. Kumar Durairajan et al., "Protective efect of tetramethylpyrazine and salvianolic acid B on apoptosis of rat cerebral microvascular endothelial cell under high shear stress," Clinical Hemorheology and Microcirculation, vol. 38, no. 3, pp. 177-187, 2008.
71. B. Shu, C. J. Zhou, Y. H. Ma et al., "Progress in studies on pharmacological efect of components rhizoma chuanxiong," Chinese Pharmacologieal Bulletin, vol. 22, no. 9, pp. 1043-1045, 2006.
72. C. Y. Guan, "Application status in the feld of cardiovascular efects of ligustrazine and existing problems," Chinese Journal of Integrated Traditional and Western Medicine, vol. 23, no. 5, p. 378, 2003.
73. L. Han and C. Ke-ji, "Study on the protective efect of ligus-trazine on myocardial ischemia reperfusion injury," Pharmaceutical Journal of Chinese People's Liberation Army, vol. 18, no. 1, pp. 41-43, 2002.